Study Summary
This trialwill study how safe and effective mosunetuzumab and glofitamab are when combined with two drugs for treating B-cell non-Hodgkin's lymphoma.
- Non-Hodgkin's Lymphoma
Treatment Effectiveness
Phase-Based Effectiveness
Study Objectives
3 Primary · 21 Secondary · Reporting Duration: Until 90 days after the final dose of study treatment
Trial Safety
Phase-Based Safety
Awards & Highlights
Trial Design
2 Treatment Groups
Arm 1
1 of 2
Arm 2
1 of 2
Experimental Treatment
112 Total Participants · 2 Treatment Groups
Primary Treatment: Arm 1 · No Placebo Group · Phase 1
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 0 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Are patients at risk of any adverse outcomes when participating in Arm 1?
"Arm 1 was assigned a score of 1, as this is an early-stage trial with limited data concerning both safety and efficacy." - Anonymous Online Contributor
Are there currently opportunities to participate in this scientific investigation?
"According to clinicaltrials.gov, this study is actively seeking participants for the trial which was posted on October 26th 2022 and modified on December 20th 2022." - Anonymous Online Contributor
Has Arm 1 been a subject of any past research initiatives?
"At present, 170 studies are underway that analyze Arm 1. Of these live trials, 27 have reached the third stage of clinical testing. The majority of investigations into this drug take place in Poznan and New York; however, 6752 different sites are conducting research on this intervention." - Anonymous Online Contributor
What therapeutic applications are typically associated with Arm 1?
"Arm 1 is typically prescribed to treat polyarticular juvenile idiopathic arthritis, but has also been used with success on conditions like refractory follicular lymphoma, rheumatoid arthritis, and cytokine release syndrome resulting from CAR-T cell therapy." - Anonymous Online Contributor
How many individuals are taking part in the present research trial?
"Affirmative. According to the listings on clinicaltrials.gov, this medical experiment was first posted on October 26th 2022 and has been in need of participants since then. The trial is seeking 112 individuals at 1 centre for recruitment." - Anonymous Online Contributor